Publications

Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses  (2024)

Authors:
Mantovani, Elisa; Martini, Alice; Dinoto, Alessandro; Zucchella, Chiara; Ferrari, Sergio; Mariotto, Sara; Tinazzi, Michele; Tamburin, Stefano
Title:
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses
Year:
2024
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
Elettronico
Referee:
Name of journal:
NPJ PARKINSON'S DISEASE
ISSN of journal:
2373-8057
N° Volume:
10
Number or Folder:
211
Page numbers:
1-17
Keyword:
Diagnostic markers; Parkinson's disease; Prognostic markers
Short description of contents:
Cognitive impairment (CI) is common in α-synucleinopathies, i.e., Parkinson's disease, Lewy bodies dementia, and multiple system atrophy. We summarize data from systematic reviews/meta-analyses on neuroimaging, neurophysiology, biofluid and genetic diagnostic/prognostic biomarkers of CI in α-synucleinopathies. Diagnostic biomarkers include atrophy/functional neuroimaging brain changes, abnormal cortical amyloid and tau deposition, and cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers, cortical rhythm slowing, reduced cortical cholinergic and glutamatergic and increased cortical GABAergic activity, delayed P300 latency, increased plasma homocysteine and cystatin C and decreased vitamin B12 and folate, increased CSF/serum albumin quotient, and serum neurofilament light chain. Prognostic biomarkers include brain regional atrophy, cortical rhythm slowing, CSF amyloid biomarkers, Val66Met polymorphism, and apolipoprotein-E ε2 and ε4 alleles. Some AD/amyloid/tau biomarkers may diagnose/predict CI in α-synucleinopathies, but single, validated diagnostic/prognostic biomarkers lack. Future studies should include large consortia, biobanks, multi-omics approach, artificial intelligence, and machine learning to better reflect the complexity of CI in α-synucleinopathies.
Web page:
https://doi.org/10.1038/s41531-024-00823-x
Product ID:
142358
Handle IRIS:
11562/1144606
Last Modified:
December 11, 2024
Bibliographic citation:
Mantovani, Elisa; Martini, Alice; Dinoto, Alessandro; Zucchella, Chiara; Ferrari, Sergio; Mariotto, Sara; Tinazzi, Michele; Tamburin, Stefano, Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses «NPJ PARKINSON'S DISEASE» , vol. 10 , n. 2112024pp. 1-17

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share